Alvotech - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
ALVO Nasdaq 2834 www.alvotech.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Alvotech

Exploring 3 High Growth Tech Stocks in the US Market - Jun 27th, 2025 5:38 am
Alvotech, Kashiv, Advanz announce study of AVT23 met primary endpoint - Jun 26th, 2025 8:25 am
Alvotech’s Lenders Lower Interest on Senior Secured Term Loan Facility - Jun 26th, 2025 2:15 am
Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Wednesday Amid Easing Middle East Tensions - Jun 25th, 2025 6:32 am
US High Growth Tech Stocks To Watch In June 2025 - Jun 25th, 2025 5:38 am
Positive Top Line Results from Confirmatory Efficacy Study for Proposed Biosimilar to Xolair® (omalizumab) - Jun 25th, 2025 2:00 am
High Growth Tech Stocks To Watch In US June 2025 - Jun 24th, 2025 11:38 am
Exploring US High Growth Tech Stocks To Watch In June 2025 - Jun 24th, 2025 5:38 am
European Medicines Agency Recommends Market Approval of AVT06, Alvotech’s Proposed Biosimilar to Eylea® (aflibercept) - Jun 23rd, 2025 2:00 am
Alvotech’s Private Placement Completed with Delivery of SDRs and Shares to Investors - Jun 11th, 2025 2:20 pm
Alvotech Participates in the Goldman Sachs Global Healthcare Conference in Miami - Jun 6th, 2025 6:30 am
Alvotech Meets Investors and Presents at the Goldman Sachs Global Healthcare Conference in Miami - Jun 6th, 2025 6:30 am
Alvotech and Dr. Reddy’s Enter into Collaboration to Co-Develop Biosimilar Candidate to Keytruda® (pembrolizumab) - Jun 5th, 2025 5:00 am
Alvotech has carried out a private placement of 7,500,000 SDRs and ordinary shares at a price of SEK 100.00 per SDR and ISK 1320.83 per ordinary share, raising gross proceeds of SEK 750 million - Jun 4th, 2025 8:29 pm
Alvotech intends to carry out a private placement of approximately 7.5 million SDRs and ordinary shares - Jun 4th, 2025 9:32 am
Alvotech Completes Acquisition of Xbrane R&D Organization and biosimilar candidate to Cimzia® - Jun 4th, 2025 5:45 am
Alvotech Meets Investors and Presents at the Jefferies Global Healthcare Conference 2025 in New York, NY - Jun 2nd, 2025 7:15 am
Alvotech and Advanz Pharma Extend Strategic Partnership to Commercialize Three Additional Biosimilars in Europe - May 28th, 2025 4:15 am
Alvotech Appoints DNB Carnegie as Liquidity Provider on Nasdaq Stockholm - May 19th, 2025 1:15 am
Trading in Alvotech’s Shares on Nasdaq Stockholm Commences Today - May 19th, 2025 12:30 am